Infliximab (Anti–Tumor Necrosis Factor α Antibody)

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

1999 • 2,358 citations

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1993 • 714 citations

Infliximab for the treatment of fistulas in patients with Crohn's disease

1999 • 529 citations

SUBCORNEAL PUSTULAR DERMATOSIS.

1956 • 311 citations

Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions

2000 • 228 citations

Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha

1987 • 219 citations

Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

2001 • 146 citations

Role of tumor necrosis factor-α in Sneddon-Wilkinson subcorneal pustular dermatosis

1991 • 60 citations

Subcorneal pustular dermatosis

2000 • 56 citations

Pyoderma gangrenosum, subcorneal pustular dermatosis and IgA paraproteinaemia

1986 • 55 citations

Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA

1991 • 50 citations

Effectiveness of Infliximab in the Treatment of Refractory Perineal Cutaneous Crohn Disease

2000 • 35 citations

Sneddon-Wilkinson disease in association with rheumatoidarthritis

2006 • 34 citations

Subcorneal pustulosis and IgA myelomatosis.

1977 • 31 citations

Subcorneal pustular dermatosis (Sneddon-Wilkinson disease)—therapeutic problems

1978 • 27 citations

Treatment of Subcorneal Pustulosis by Etretinate

1987 • 15 citations

Subcorneal pustular dermatosis responsive to narrowband (TL-01) UVB phototherapy

1997 • 11 citations

Subcorneal Pustular Dermatosis

1963 • 3 citations

Cited By (0)

No citing papers found in database